drugset / Trial / NCT01023178

Comparison of Transdermal and Oral Estrogens in Adolescent Girls With Ovarian Failure

NCT01023178

Completed 20 enrolled Stanford University
RandomizedParallel-groupOpen-labelTreatment

Summary

To directly compare the safety (by laboratory evaluation) and efficacy (feminization and growth) of three commonly used estrogen preparations in adolescent patients with ovarian failure, either due to congenital causes (Turner syndrome) or medical therapies. We hypothesize that transdermal estrogen will have equivalent efficacy and a more favorable safety profile in comparison with conventional oral estrogen replacement.

Timeline

Start
2007-02
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator 17-beta estradiol Unknown 0.05 mg Oral
Comparator 17-beta estradiol Unknown 1 mg Oral
Comparator Progesterone Other / unclassified
Comparator conjugated estrogens Other / unclassified 0.625 mg Oral